Trump's doubling down on trade issues. If you can't stand the pressure, then raise cash. Jim Cramer has your game plan for next week.

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Wednesday's trending market topics from the floor of the New York Stock Exchange.

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer thinks Barclay's $29 price target on Valeant Pharmaceuticals is "very right."

Jim Cramer weighs in on Royal Caribbean, Allergan, Tyson Foods, Carrizo Oil & Gas, Valeant Pharmaceuticals, Okta, CRISPR Therapeutics and more.

Jim Cramer says the hope that the trade dispute with China can be worked out was the fuel for this rally.

The Indian tycoon and his empire are facing allegations of fraud by an American short-seller. Their answer does not convince investors for the moment.

The Justice Department wants to ban Sam Bankman-Fried, the former CEO of bankrupt FTX, from speaking to former employees of the crypto exchange.

The billionaire had proposed a controversial plan to end the Russia-Ukraine conflict, which now has lasted nearly a year.

The cruise line has almost fully returned to normal after the covid pandemic, but one very popular activity hasn't been brought back.